Early malnutrition is a risk factor for depression and schizophrenia. Since the offspring of malnourished dams exhibit increased brain levels of serotonin (5-HT), a tryptophan-derived neurotransmitter involved in the pathophysiology of these mental disorders, it is believed that the deleterious effects of early malnutrition on brain function are due in large part to altered serotoninergic neurotransmission resulting from impaired tryptophan (Trp) metabolism. However, tryptophan is also metabolized through the kynurenine (KYN) pathway yielding several neuroactive compounds including kynurenic (KA), quinolinic (QA) and xanthurenic (XA) acids. Nevertheless, the impact of perinatal malnutrition on brain kynurenine pathway metabolism has not been examined to date. Here, we used ultra-performance liquid chromatography-tandem mass spectrometry for the simultaneous quantification of tryptophan and a set of seven compounds spanning its metabolism through the serotonin and kynurenine pathways, in the brain of embryos and adult offspring of rat dams fed a proteinrestricted (PR) diet. Protein-restricted embryos showed reduced brain levels of Trp, serotonin and KA, but not of KYN, XA, or QA. In contrast, PR adult rats exhibited enhanced levels of Trp in the brainstem and cortex along with increased concentrations of 5-HT, kynurenine and XA. The levels of XA and KA were also increased in the hippocampus of adult PR rats. These results show that early protein deficiency induces selective and long-lasting changes in brain kynurenine metabolism. Given the regulatory role of KYN pathway metabolites on brain development and function, these changes might contribute to the risk of developing psychiatric disorders induced by early malnutrition. Keywords: brain, Foetus, kynurenine, metabolic programming, protein restriction, serotonin. A large body of epidemiological evidence indicates that malnutrition during in utero and/or neonatal development results in long-lasting learning deficits and a high risk of developing neurological and psychiatric disorders in later life such as depression and schizophrenia (Brown et al. 2000; Costello et al. 2007; Brown and Susser 2008; Xu et al. 2009 ). In rodents, the offspring of malnourished dams exhibit impaired learning (Tonkiss and Galler 1990; Fukuda et al. 2002) and enhanced behavioural responses to stress (Trzct nska et al. 1999; Levay et al. 2008) , and these alterations are associated with a number of neuroanatomical and neurochemical changes including a reduced number of Received May 13, 2016; revised manuscript received September 14, 2016; accepted October 14, 2016. Address correspondence and reprint requests to Francisco Bolaños-Jim enez, CHU-Hôtel Dieu, HNB1-UMR PhAN, 1280 Physiologie des Adaptations Nutritionnelles, Place AlexisRicordeau 44096 Nantes, Cedex 1, France. E-mail: Francisco.Bolanos@univ-nantes.fr
A large body of epidemiological evidence indicates that malnutrition during in utero and/or neonatal development results in long-lasting learning deficits and a high risk of developing neurological and psychiatric disorders in later life such as depression and schizophrenia (Brown et al. 2000; Costello et al. 2007; Brown and Susser 2008; Xu et al. 2009 ). In rodents, the offspring of malnourished dams exhibit impaired learning (Tonkiss and Galler 1990; Fukuda et al. 2002) and enhanced behavioural responses to stress (Trzct nska et al. 1999; Levay et al. 2008) , and these alterations are associated with a number of neuroanatomical and neurochemical changes including a reduced number of neurons and synaptic contacts (Di az-Cintra et al. 1991; Granados-Rojas et al. 2002) along with an altered function of several neurotransmitter systems (Laino et al. 1993; Almeida et al. 1996) . However, these experimental observations do not provide any information about the causeeffect relationship between the lack of one, or several, nutrients during the critical stages of development and disease susceptibility later in life.
Here, we examined the potential involvement of tryptophan (Trp) on the psychiatric and neurological disorders induced by perinatal undernutrition. Trp is an essential amino acid that serves as precursor for the synthesis of several neuro-active compounds through the serotonin (5-HT) and kynurenine (KYN) pathways. Namely, 5-HT modulates cell proliferation and differentiation as well as neuronal migration and synaptogenesis during embryonic development (Gaspar et al. 2003; . At adulthood, this neurotransmitter regulates learning and memory processes (Olvera-Cort es et al. 2013; Stiedl et al. 2015) and is involved in the pathophysiology of several neuropsychiatric diseases including anxiety (Albert et al. 2014) , depression (Dell'Osso et al. 2016) , schizophrenia (Lin et al. 2015; Baou et al. 2016) and autism (Muller et al. 2016) . Kynurenic acid (KA) and quinolinic acid (QA), two products of the KYN pathway, have also been associated with these neurological disorders as well as with Huntington's, Alzheimer's, and Parkinson's diseases because of their capacity to act as antagonist and agonist, respectively, of glutamate NMDA receptors (Sathyasaikumar et al. 2011; Myint and Kim 2014; Yang et al. 2014; Maddison and Giorgini 2015a; R eus et al. 2015) .
Previous studies have shown that protein or calorie restriction during gestation and/or lactation result in increased brain levels of serotonin (Mokler 1999 ; (Stern et al. 1975; Miller et al. 1977; Hern andez et al. 1989) . This indicates that the brain disorders exhibited by individuals malnourished in early life are due, at least in part, to altered tryptophan metabolism. However, in spite of the neurological effects of the kynurenine pathway metabolites and the fact that more than 90% of total body tryptophan is metabolized along this pathway (Leklem 1971; G al and Sherman 1980) , whether in utero and/or neonatal malnutrition alters the brain concentration levels of KYN and its metabolites has not been examined to date. To get a complete picture of the short and long-term effects of maternal malnutrition on Trp metabolism in the brain of the offspring, here we performed simultaneous quantification, by ultra-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS), of tryptophan and a set of seven compounds spanning its metabolism through the serotonin and kynurenine pathways in the placenta and brain of embryos and adult offspring of dams fed a low-protein diet during gestation and lactation. In addition, to determine whether maternal protein restriction induces selective effects on the serotoninergic system, we quantified, within the same samples and in the same analytical run, the concentration of dopamine (DA) and norepinephrine (NE), two compounds that, together with 5-HT, constitute the family of monoamine neurotransmitters. Like serotonin, DA and NE act as learning signals and have been associated with the physiological alterations underlying depression and schizophrenia (Lechin and van der Dijs 2005; Carlsson and Carlsson 2006; Hamon and Blier 2013) .
Material and methods

Animals and nutritional manipulations
All experiments were performed in accordance with the European Communities Council Directive of 24 November 1986 (86/609/ EEC) and the Principles of laboratory animal care (NIH publication no. 85-23, revised 1985) , and were approved by the Ethical Committee for Animal Experimentation of the Pays de la Loire (CEEA PdL 2012.182).
Virgin female Wistar rats weighing 200-220 g were obtained from Charles River (Saint-Germain-sur-l'Arbresle, France) and mated to 3-month-old males of the same strain. After confirmation of mating, pregnant rats were housed individually and fed ad libitum either a control (170 g protein/Kg) or an isocaloric low-protein (LP) diet (80 g protein/Kg). The diets were provided by the Department of Nutrition of the Federal University of Pernambuco (Brazil) and their composition has been described previously (Nascimento et al. 2013) . The day on which the dam was determined to be sperm positive was considered embryonic day 1 (E1). Animals were maintained in an environmentally controlled clean air room with a temperature of 21 AE 2°C and a 12 h dark/12 h light cycle for the duration of the experiment.
Tissue sampling
At E13 and E17, a set of pregnant rats from each experimental group, control (C) and protein-restricted (PR), were anaesthetized with 2% isoflurane. Foetuses and placenta of each female were then extracted by caesarean section. The brain of each foetus was dissected and divided into forebrain and hindbrain and immediately frozen together with the placenta samples in liquid nitrogen and kept at À80°C until analysis. In addition, a blood sample was collected from the dams by cardiac puncture before their killing by cervical dislocation. The remaining dams continued to be fed the control or the low-protein diets through gestation and lactation. One day after birth, litter size was adjusted at random to eight pups per dam maintaining an equal sex ratio. At weaning (21 days), all control and PR pups were fed standard chow until the end of the experiment. At 7 months of age, animals were killed by exposure to a CO 2 -enriched atmosphere followed by cervical dislocation. Trunk blood was collected and the cerebral cortex, brainstem and hippocampus were dissected, frozen immediately in liquid nitrogen and stored at À80°C until analysis. At the end, a total number of 12 control dams (six for foetus and six for adults), and 12 PR dams (six for foetus and six for adults), were used, such that the presented results correspond to the combined data from six animals born to six different dams.
Chemicals and reagents
Water, acetonitrile, methanol, formic acid, EDTA and ammonium acetate were obtained from Biosolve (Valkenswaard, Netherlands).
, QA, L-KYN, 5-hydroxyindole acetic acid (5-HIAA), KA, 5-HT, nicotinic acid (NA), xanthurenic acid (XA), cafeic acid, 2-chloroadenosin (2-CAD), DA, NE were purchased from Sigma Aldrich (Saint-Quentin Fallavier, France) and were dissolved in methanol containing 0.1% of formic acid to reach concentrations at 20 mM. These working solutions were stored as single-use aliquots at À20°C.
Ultra-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) We used a Xevo TQD Mass Spectrometer with an electrospray (ESI) interface and an Acquity H-Class UPLC TM device (Waters Corporation, Milford, MA, USA) and the methodology developed by Zheng et al. (2012) for the simultaneous quantification of tryptophan and a set of eight compounds spanning its metabolism through the serotonin and kynurenine pathways (Fig. 1) . The concentrations of the neurotransmitters dopamine and noradrenalin were also determined within the same samples and in the same analytical run.
In brief, 50 mg of placenta or brain tissue were homogenized in 200 lL of an ice-cold extraction solution containing 2.7 mM EDTA, 1% formic acid and a pool of exogenous internal standards at the following concentrations: 50 lM 15 N 2 -Trp, 200 lM cafeic acid and 5 lM 2-CAD. Thereafter, 500 lL of ice-cold acetonitrile were added to the homogenate and, after centrifugation at 15 000 g for 15 min, the supernatant was recuperated and evaporated to dryness under a nitrogen stream at room temperature. The same extraction protocol was used for the analysis of the circulating levels of the kynurenine pathway metabolites using 50 lL of plasma. To generate calibration curves, standard solutions were prepared in the same way by serial dilutions of compounds (Trp, DA, QA, NE, 5-HT, KYN, NA, 5-HIAA, KA and XA) in 2.7 mM EDTA aqueous solution containing 0.1% of formic acid. Calibration ranges are detailed in the Table S1 . Dried samples were then dissolved in 100 lL of 2.7 mM EDTA aqueous solution containing 0.1% of formic acid and 2 lL of samples were injected into the LC-MS/MS system for analysis.
Compounds were separated on an Acquity HSS T3 column (2.1 9 100 mm, 1.7 lm, Waters) at 30°C with a linear gradient of mobile phase B (acetonitrile containing 0.5% formic acid and 2.5 mM ammonium acetate) in mobile phase A (water containing 0.5% formic acid and 2.5 mM ammonium acetate) and at a flow rate of 400 lL/min. Mobile phase B (1%) was linearly increased to 25% for 6 min, then returned to the initial condition for 10 s, and kept constant for 1.40 min prior the next injection. Compounds were then detected by the mass spectrometer with the ESI interface operating in the positive ion mode (capillary voltage, 3.5 kV; desolvation gas (N 2 ) flow and temperature, 900 L/h and 450°C; source temperature, 150°C). The multiple reaction mode was applied for MS/MS detection as detailed in Table S1 .
Data acquisition and analyses were performed with MassLynx â and TargetLynx â software respectively (version 4.1; Waters).
Compound concentrations were calculated using calibration curves plotted from standard solutions. Exogenous internal standards were used to normalize the detector response as follows: Real-time quantitative RT-PCR A quantity of 2 lg of purified RNA extracted from the hindbrain of embryos at E17 and from the brainstem of 7 months-old animals was reverse transcribed using M-MLV Reversed Transcriptase (Promega France, Charbonni eres-les-Bains, France) in a total volume of 25 lL. The resulting cDNA was diluted 40-fold in DNAse and RNAse-free water. Thereafter, 5 lL of each cDNA diluted sample was used as template for PCR amplification using SYBR Green (Qiagen, Courtaboeuf, France) as fluorogenic intercalating dye. The relative expression levels were calculated using the comparative 2 ÀDDCt method (Livak and Schmittgen 2001) and b-2-microglobulin RNA as housekeeping gene. The primers used for the amplification were: Tryptophan hydroxylase 2 (TPH-2), forward: ATCCCAAGTTC GCTCAGTTTTCTC3, reverse: ACGCCCGCAGTTGACCTTC; indoleamine 2,3-dioxygenase 1 (IDO1), forward: ATGGCGTATG TGTGGAAC, reverse: TGCGTAAGACAGAATGGG; kynurenine mono-oxygenase (KMO), forward: GCTTCCAACGCATAGT GATG, reverse: GGCAGGCAACAGAAAGAAATC3; kynureninase (KYNU), forward: CAACATTCCTGCCATTACACAAGC, reverse: GCACCAGCCAGACCTCCAG; 3-hydroxyanthranilate 3,4-dioxygenase (HAAO), forward: AGCCCAACCCTGACCAA CTG; reverse: GGATGTGCCTGCCTGAAGC; b-2-microglobulin forward: GATGGCTCGCTCGGTGAC, b-2-microglobulin reverse CGTAGCAGTTGAGGAAGTTGG.
Statistical analysis
Experimental results are expressed as means AE SEM. Data were analysed using GraphPad Prism version 5.00; GraphPad Software Inc., San Diego, CA, USA for Windows. Mass spectrometry data for maternal plasma were first tested for normality using the normal probability plot method. An r 2 value ≥ 0.85 along with the fall of all the data within the 95% confidence intervals of the regression line was used as criteria of a normal distribution. The statistical significance of the effects of pregnancy and of the combined effects of pregnancy and protein restriction on tryptophan metabolites in maternal plasma were assessed, respectively, by one-way and two-way ANOVA using in the latter case pregnancy and maternal diet as factors. Both analyses were followed by post hoc comparisons tests as appropriate. Statistical differences between control and PR rats for the rest of the data were assessed by Mann-Whitney test. Statistical significance was set at p < 0.05.
Results
Effect of protein restriction on the concentrations of kynurenine pathway metabolites in maternal plasma
Previous studies have shown that pregnancy is associated with increased plasmatic concentrations of Trp and kynurenine (Schr€ ocksnadel et al. 2003; Badawy 2015) . In agreement with these observations, the circulating levels of tryptophan and of all the examined kynurenine pathway metabolites were significantly higher in control pregnant rats as compared to age-matched virgin animals ( Fig. 2a-f ).
Protein restriction abolished the pregnancy-induced increase in the plasmatic levels of tryptophan as indicated by the identical plasmatic concentration of this amino acid in pregnant and non-pregnant protein-restricted rats (Fig. 2a) . Nevertheless, gestating rats fed the low-protein diet also exhibited higher plasmatic concentrations of the kynurenine pathway metabolites, with the exception of quinolinic acid, than their non-pregnant counterparts ( Fig. 2b-f ). Moreover, compared to control pregnant dams, protein-restricted gestating rats displayed decreased circulating levels of tryptophan ( Fig. 2a) , along with reduced plasma concentrations of all the examined kynurenine pathway metabolites with the exception of anthranilic acid ( Fig. 2b-f ). This effect was observed both at 13 and 17 days of gestation. Noticeably, with the exception of KYN, virgin rats showed the same plasmatic concentrations of tryptophan and kynurenine metabolites independently of the feeding diet indicating that, under our experimental conditions, protein malnutrition interferes with the metabolic adaptations occurring during pregnancy and not with the basal metabolism of tryptophan.
Effect of maternal protein restriction on TrP metabolism in placenta and the foetal brain have recently demonstrated that Trp is transformed to 5-HT in the placenta and that this biosynthetic pathway serves as unique source of 5-HT for the foetal forebrain from E10 to E15. After this developmental stage, the major source of 5-HT to the embryonic forebrain is the one derived from the metabolism of Trp within the hindbrain serotoninergic neurons. However, to the best of our knowledge, there are no data about the concentration of the different kynurenine pathway metabolites in the brain embryo at these early developmental stages. Therefore, with the aim to dissociate the effects of undernutrition on Trp metabolism in the embryonic brain from those in the placenta, we analysed the effects of maternal protein restriction on Trp metabolism at E13 and E17 in these two tissues.
In agreement with the observations in plasma, protein restriction induced a significant decrease in the concentration of Trp in the placenta both at E13 an E17 that was correlated with a reduced concentration of 5-HT and 5-HIAA (Table 1) . There was also a significant reduction in the concentration of Trp, serotonin, and 5-HIAA in both the hindbrain and forebrain of malnourished embryos at E13. In contrast, we found no differences in brain tryptophan levels between control and protein-restricted embryos at E17 (Table 1) . Surprisingly, however, the concentration of serotonin was reduced as well as that of 5-HIAA though this latter metabolite was decreased in the forebrain but not in the hindbrain. Consequently, at E17, the 5-HIAA to 5-HT ratio increased in the hindbrain and decreased in the forebrain of malnourished embryos (Table 1 ), indicating that protein restriction induces regional, and opposite, effects on serotonin turnover in the foetal brain at this developmental stage.
Concerning the kynurenine pathway, the concentrations of KYN, KA, QA and anthranilic acid (AA) were reduced in the placenta at E17 but not at E13 (Table 2 ). In contrast, there were no major differences at E13 and E17 in the effects induced by protein malnutrition in the brain. At these two developmental stages we observed that, although the concentration of KYN was not affected by protein restriction, PR embryos exhibited a significant reduction in the concentration levels of kynurenic acid and anthranilic acid without any change in the levels of xanthurenic acid and quinolinic acid. Of note, however, the concentration of this latter metabolite was increased by 54% in forebrain of PR embryos at E13. As a consequence, the QA/KA and XA/KA ratios were increased (Table 2) . Conversely, the KA/KYN and the KA/QA ratios were decreased. An enhanced QA to KA ratio is associated with ischaemic damage, whereas the KA/KYN and the KA/QA ratios are reduced in patients with major depressive disorder (Myint et al. 2007; Savitz et al. 2015) .
Effect of maternal protein restriction on TrP metabolism at adulthood
In agreement with previous studies, we observed a significant increase in the concentration of serotonin in the brainstem, hippocampus and cortex of adult rats born to proteinrestricted dams (Fig. 3a-c) . These changes were paralleled by enhanced levels of tryptophan in the brainstem and cortex as well as by decreased cortical serotonin turnover (5-HIAA/ 5-HT controls = 1.20 AE 0.14 vs. 5-HIAA/5-HT PR = 0.80 AE 0.02; p < 0.01). Malnutrition in early life also induced long-term changes in the kynurenine pathway of tryptophan as indicated by the increased concentration of kynurenine in the brainstem and cortex of the adult offspring born to PR dams ( Fig. 3d and f) . Adult PR rats exhibited also enhanced brain concentrations of kynurenic acid and xanthurenic acid as compared with their control counterparts, but these changes were not homogeneous among the different brain regions. Thus, the concentration of kynurenic acid was significantly enhanced in the hippocampus (Fig. 3e) but not in the brainstem (Fig. 3c ) or in cortex (Fig. 3f) . Indeed, xanthurenic acid was the only metabolite of the kynurenine pathway whose concentration was increased in all examined brain regions ( Fig. 3d-f) .
In contrast to serotonin, which does not cross the brainblood barrier, kynurenine is transported into the brain from the circulation by the brain capillary large neutral amino acid carrier (Speciale et al. 1989; Fukui et al. 1991) . Consequently, the aforementioned described changes in the brain concentration of kynurenine and kynurenine metabolites might be secondary to a modification of tryptophan metabolism at the peripheral level. To explore this possibility, plasma from trunk blood collected at the time of killing was assayed for tryptophan and kynurenine metabolites. As shown in Fig. 4 , we found no differences in the plasmatic levels of Trp and kynurenine metabolites between control and protein-restricted adult rats. This indicates that the peripheral metabolism of tryptophan through the kynurenine pathway is not affected by early malnutrition. Interestingly, both control and PR male rats exhibited significantly lower levels of several kynurenine metabolites compared to nonpregnant females (Fig. 4) .
Effect of maternal protein restriction on dopamine and noradrenaline
The placental concentrations of both dopamine and norepinephrine were significantly reduced by maternal protein restriction (DA control = 4281 AE 220 ng/g tissue vs. DA protein-restricted 2229 AE 186 ng/g tissue p < 0.01; NE control = 955 AE 116 ng/g tissue vs. NE proteinrestricted = 624 AE 42 ng/g tissue, p < 0.05). Nevertheless, we found no differences between control and PR animals in the brain levels of these neurotransmitters neither in embryos nor in adult animals with the exception of a reduced concentration of NE in the forebrain of protein-restricted versus control embryos (control = 1301 AE 21 ng/g tissue vs. protein-restricted 1070 AE 55, p < 0.05).
Effect of perinatal malnutrition on mRNA expression for genes encoding several enzymes regulating tryptophan metabolism The first step in serotonin and kynurenine synthesis from tryptophan in the brain is catalysed, respectively, by the enzymes TPH2 and IDO. KYN is further converted to kynurenic acid, anthranilic acid and 3-hydroxy kynurenine through the action of, respectively, kynurenine aminotransferase 2 (KAT2), KYNU and KMO. In turn, 3-hydroxy kynurenine serves as precursor for the synthesis of xanthurenic acid and 3-hydroxyanthranilic acid. This latter compound is ultimately converted into quinolinic acid and NAD under the action of HAAO (Fig. 1) . We therefore performed a series of real-time PCR experiments in order to determine whether the effects of protein restriction could be explained by an altered expression of the mRNAs encoding for these different genes. As illustrated in Fig. 5(a) , maternal protein restriction induced a significant reduction of KMO expression in the embryonic brain without affecting TPH2, IDO or KAT2 gene expression. In contrast, adult malnourished animals exhibited a significant reduction of TPH2 gene expression along with enhanced KMO mRNA levels in the adult brainstem (Fig. 5b) . Under our experimental conditions, we were unable to detect KYNU and HAAO mRNA expression in the embryonic hindbrain and adult brainstem. Concerning the other brain regions, we observed a decreased expression of IDO and HAAO in the hippocampus that was associated with increased mRNA levels coding for KYNU (Fig. 5c) , whereas in the cerebral cortex the expressions of KAT2, KYNU and HAAO were down-regulated (Fig. 5d ).
Discussion
The herein presented results show that maternal protein restriction in the rat induces selective changes in kynurenine pathway metabolism in the embryonic brain which are opposite to those exhibited by adult offspring born to protein-restricted dams. In particular, although maternal protein restriction had no effect on the concentration of kynurenine and xanthurenic acid in the embryo, the concentration of these metabolites was increased by 75% and 46%, respectively, in the brain of adult PR rats. Moreover, proteinrestricted embryos exhibited reduced levels of kynurenic acid both in hindbrain and forebrain. In contrast, the concentration of this metabolite was increased 4.7-fold in the hippocampus but not in the brainstem or cortex of PR adult rats. The metabolism of tryptophan through the kynurenine pathway in the brain is initiated by the oxidative cleavage of the indole-ring of TrP by IDO. This reaction, which is the rate limiting step of the kynurenine pathway, results in the formation of N-formylkynurenine followed by kynurenine in an ensuing step. The subsequent metabolism of Kyn occurs via one of three mechanisms: (i) its deamination by the KAT family of enzymes leads to the production of KA; (ii) its degradation by kynureninase results in the production of anthranilic acid; (iii) its hydroxylation by KMO produces 3-hydroxykynurenine (3-HK) which serves as an intermediate for the production of xanthurenic acid, quinolenic acid, nicotinic acid and ultimately NAD (Fatokun et al. 2013) . In theory, any modification of the mRNA levels encoding IDO should be followed by paralleled changes in KYN levels. Similarly, an increased expression of KMO should shunt KYN metabolism towards enhanced XA and QA production Fig. 4 Effect of early protein restriction on the plasmatic concentration of tryptophan and kynurenine pathway metabolites in adulthood. Data correspond to the determinations (means AE SEM, n = 6), performed in 7-month-old rats born to dams fed a standard (control) or a low-protein diet during gestation and lactation. For comparison, the values obtained in 3-4-month-old virgin female rats are included. *p < 0.05; **p < 0.01; ***p < 0.001; compared to male control rats; § § p < 0.01. The Mann-Whitney test was used in both cases.
and, therefore, induce a collateral reduction of KA. Conversely, an increase of KAT2 expression should result in enhanced levels of KA and decreased concentrations of XA and QA.
Real-time PCR experiments in the embryonic hindbrain and in the adult brain showed that control and PR animals exhibit a similar expression of mRNA for IDO with the exception of the hippocampus in which the levels decreased by 50% in PR rats compared with controls. However, in spite of these transcriptional changes, there we no significant differences in the hippocampal concentration of KYN between control and PR adult rats. Moreover, KMO gene expression was decreased and increased, respectively, in the embryonic and adult brain of PR rats. The reduced expression of KMO in malnourished embryos was associated with decreased hindbrain and forebrain concentration of KA, whereas the concentration of XA and QA did not differ between control and PR embryos. In contrast, maternal protein restriction induced paralleled effects on brain KMO expression and XA levels in the brainstem at adulthood. However, PR affected nor the concentration of KA neither that of QA. Finally, we observed a reduced expression of KAT2 in the cerebral cortex of PR rats in relation to controls. Yet, this reduction was not associated with an increased level of KA. Similarly, PR rats exhibited a significant increase in the hippocampal content of KA without any modification of KAT2 gene expression. Collectively, these observations indicate that the altered metabolism of kynurenine induced by maternal protein restriction cannot be fully explained by a modification within the brain of the mRNA levels encoding the key enzymes regulating the kynurenine pathway.
Kynurenine is transported into the brain from the circulation by the brain capillary large neutral amino acid carrier (Speciale et al. 1989; Fukui et al. 1991) . It has also been shown that the placenta has the capacity to metabolize tryptophan through the kynurenine pathway (Manuelpillai et al. 2005; Sano et al. 2016) . We found no differences between control and PR animals in the placental determined by real-time quantitative PCR using brain samples from E17 embryos and from 7-month-old male rats born to control or protein-restricted dams that were fed a standard diet since weaning. Fold changes in gene expression were calculated by dividing the 2 ÀDCt value of each sample by the averaged 2
ÀDCt of the respective control group. *p < 0.05; **p < 0.01 compared with control animals (MannWhitney test).
concentrations of KYN and kynurenine metabolites at E13 with the exception of a 59% increase in the concentration of XA in placenta from PR dams as compared with the levels in control tissue. However, the concentration of this metabolite was the same in the brain of control and PR embryos. In contrast, the concentration of KA and AA was decreased while that of QA was increased in the forebrain of E13 malnourished embryos. Similarly, at gestational day 17, protein-restricted dams exhibited decreased plasma and placental levels of KYN and of all kynurenine pathway metabolites. Yet, the levels of KYN, XA and QA in the hindbrain and forebrain of PR embryos were the same as in control embryos. Moreover, control and PR adult rats exhibit similar plasmatic concentrations of kynurenine metabolites. These results show that, though protein restriction altered the concentrations of KYN and its metabolites in maternal blood and placenta, neither the transfer of KYN metabolites from the maternal circulation to the foetus nor their release into the circulation are associated with the observed changes in kynurenine pathway metabolism in the embryonic and adult brain. A similar conclusion was reached by Sano et al. (2016) who observed that protein restriction does not alter the transfer of stable isotope-labelled tryptophan from the mother to the foetus. Further studies are therefore required to determine the mechanisms underlying the altered metabolism of KYN in the offspring of protein-restricted dams. Interestingly, we found that the absolute plasmatic concentration of some kynurenine pathway metabolites were significantly higher in female non-pregnant rats than in adult male rats and that these concentrations were further increased by pregnancy. This observation extends the results of previous studies that have documented gender differences in brain tryptophan metabolism through the serotonin pathway both in rats (Carlsson and Carlsson 1988) and humans (Nishizawa et al. 1997) and confirm that pregnancy is associated with an important remodelling of tryptophan metabolism.
Several studies have documented that a modification of the cerebral concentration of the metabolites of the kynurenine pathway leads to impaired brain function and is associated with neurological and psychiatric disorders. In particular, enhanced brain levels of kynurenine and kynurenic acid have been reported in schizophrenic patients (Erhardt et al. 2001; Schwarcz et al. 2001) . There is also a large body of evidence showing that early malnourished individuals are at high risk of developing schizophrenia (Hoek et al. 1998; Brown and Susser 2008; Xu et al. 2009 ). However, the actual mechanisms responsible for the increased brain levels of KYN and KA in schizophrenic patients remain unknown. We also ignore how and through which mechanisms prenatal nutrient restriction enhances the susceptibility of developing this mental disorder. In this respect, the results presented here, showing increased levels of KYN and KA in the brains of adult rats born to protein-restricted dams, suggest that altered kynurenine pathway metabolism might be a key link between perinatal malnutrition and the development of schizophrenia later in life.
Altered kynurenine pathway metabolism might also contribute to the cognitive deficits generally observed in early malnourished individuals. Actually, experimental studies in rodents have shown that increasing the concentration of KA in brain results in impaired spatial and working memory (Chess et al. 2007) and that the levels of this metabolite are enhanced by the exposure to chronic social defeat stress (Fuertig et al. 2015) . Interestingly, adults rats treated for a short period of time during their first days of postnatal life or during adolescence with kynurenine (Trecartin and Bucci 2011; Iaccarino et al. 2013) , or kynurenic acid (Akagbosu et al. 2012; DeAngeli et al. 2015) , exhibit reduced social behaviour and impaired memory. Adult offspring of dams fed an enriched kynurenine diet from the last third of gestation to the end of lactation exhibit similar cognitive deficits (Pocivavsek et al. 2012 (Pocivavsek et al. , 2014 . Notably, these changes are associated with increased KA levels in the prefrontal cortex, decreased expression of the a7 nicotinic acetylcholine receptor and metabotropic glutamate receptor 2 and reduced synaptic density (Pershing et al. 2015) . All together, these observations reveal that a transient alteration of the kynurenine pathway during early life has enduring effects on brain function.
It has been known for long time that kynurenic acid is an antagonist of the a7 nicotinic acetylcholine receptor, as well as of all glutamate ionotropic receptors, whereas QA acts as selective NMDA receptor agonist (Stone 1993; Hilmas et al. 2001; Schwarcz and Pellicciari 2002; Maddison and Giorgini 2015b) . More recently, XA has been shown to stimulate metabotropic glutamate (mGlu)2/3 receptors (Fazio et al. 2015) . Therefore, the neurological effects of the kynurenine pathway metabolites are mainly due to the modulation of glutamate signalling and are the result of a subtle equilibrium between their stimulatory and inhibitory effects on glutamate receptors. This equilibrium is of particular concern for the structural organization of the brain because of the key role of glutamate receptors in axon formation and maturation of synaptic contacts during in utero and neonatal development. Indeed, NMDA receptor blockade in neonatal rats has been reported to increase neuronal apoptosis, reduce volume and neuronal number within the hippocampus and alter hippocampal NMDA receptor expression (Ikonomidou et al. 1999; Harris et al. 2003) . Moreover, it has been documented that excessive activation of NMDA receptors results in a massive influx of Ca 2+ into the cell followed by the translocation of pro-apoptotic genes to the mitochondria, activation of caspases and free radical formation leading to loss of nerve cells (Dong et al. 2009 ). Here, we observed a more than a two-fold increase in the ratio of QUIN to KA in the brain of protein-restricted embryos, which is indicative of an overstimulation of NMDA receptors. This observation suggests that the alterations of the kynurenine pathway induced by maternal protein restriction might contribute to the long-lasting brain structural abnormalities exhibited by the offspring of malnourished dams comprising decreased number of neurons, spines, synapses and dendritic arborisations in the hippocampal formation (Di az-Cintra et al. 1991; Granados-Rojas et al. 2002) .
Concerning the impact of maternal malnutrition on the metabolism of tryptophan via the serotonin pathway, there was a significant reduction in the concentration of serotonin in the placenta along with decreased levels of 5-HT in the hindbrain and forebrain of PR embryos. These changes were observed at both 13 and 17 days of gestation. Interestingly, however, protein restriction induced effects of different magnitude on 5-HT turnover in hindbrain and forebrain at E17. Actually, although E13 malnourished embryos exhibited an almost identical reduction of 5-HT levels in hindbrain (À61%) and forebrain (À58%), in E17 PR embryos the concentration of 5-HT was reduced by 47% in hindbrain and by 18% in forebrain. In addition, while at E13, malnourished embryos exhibited an increased 5-HIAA/5-HT ratio in both brain regions, at E17 the 5-HIAA/5-HT ratio remained increased in hindbrain but was reduced in forebrain. A decreased 5-HIAA to 5-HT ratio is indicative of reduced serotonin release and, consequently, of decreased 5-HT activity.
Brain serotonin synthesis takes place exclusively in a group of neurons located along the midline of the brainstem from which they send ascending projections to the entire brain. In rodents, these neurons start to develop at E12 and acquire the capacity to synthesize 5-HT about 1 day later (Lidov and Molliver 1982; Aitken and T€ ork 1988; Lauder 1990) . However, it is not until E17-E19 that 5-HT axons innervate all areas of the brain (Lidov and Molliver 1982; Aitken and T€ ork 1988) . Before this developmental stage, placental serotonin acts as unique source of 5-HT to the foetal forebrain . Consequently, the reduced levels of 5-HT in the forebrain of malnourished embryos at E13 are likely due to the impaired synthesis of 5-HT in the placenta while the neurochemical alterations observed at E17 result from the effects of protein restriction on 5-HT neurons themselves. Collectively, our results therefore show that maternal protein restriction impairs placental 5-HT synthesis, affecting negatively serotonin levels in the early developing forebrain, and induces regional differences in serotonin neurotransmission within the foetal brain with enhanced serotonin activity in hindbrain and reduced serotonin turnover in forebrain. These regional differences might explain why only minimal brain structural defects are observed in early malnourished animals in spite of the well-documented stimulatory role of serotonin on cell proliferation and differentiation and axon guidance. Indeed, the barrel field area of the somatosensory cortex in rodents is transiently and densely innervated by serotoninergic neurons during the early period of postnatal development. Yet, maternal protein or calorie restriction induce marginal defects on barrel formation as compared to the significant reduction of barrel field areas produced by the administration of 5-HT depleting drugs (Persico et al. 2000; Guti errez-Ospina et al. 2002) .
Our results about the effects of protein restriction on serotonin, are in line with the data of Ramanamurthy (1977) and Persico et al. (2000) who have also observed lower levels of 5-HT in the brain of neonatal rats born to PR dams as compared with control pups. Nevertheless, our observations are at odds with the results of other studies showing that Trp and serotonin levels are increased in the brain of embryos and pups of malnourished dams (Miller et al. 1977; Minkowski et al. 1981; Hern andez et al. 1989) . These conflicting results might be accounted for by methodological differences such as the use of global calorie restriction or ligation of the uterine artery as nutritional insult and the quantification of 5-HT in a pool of whole brain from different embryos as opposite to protein malnutrition and the determination of serotonin in separate brain regions of a single embryo as reported here.
Strikingly, as for some metabolites of the kynurenine pathway, adult PR rats exhibit increased brain levels of Trp and serotonin. Circulating tryptophan is predominantly bound to albumin such that, under normal physiological conditions, it is only about 10% of Trp which is present in free form in blood and, therefore, available for transport into the brain (McMenamy and Oncley 1958; Tagliamonte et al. 1973) . Previous studies have shown that the free fraction of Trp in plasma is increased in pups nursed by dams fed a protein-restricted diet (Miller et al. 1977) , as well as in low birth-weight infants (Hern andez et al. 1989; Manjarrez et al. 1998) , because of the low levels of blood albumin resulting from malnutrition. This would lead to an increased transport of Trp into the brain and, consequently, to enhanced cerebral 5-HT synthesis. This mechanism has been proposed to explain the increased levels of serotonin in the brain of malnourished neonatal rats (Miller et al. 1977; Manjarrez et al. 1998) , but cannot account for the differences between the control and PR adult animals reported here since it is very unlikely that the levels of albumin in blood remain below normal values after 6 months of nutritional rehabilitation. Instead, the differences in the brain levels of Trp and 5-HT between control and PR adult rats could be associated to the metabolic perturbations induced by perinatal protein restriction. Actually, it is well established that early malnourished individuals are also at high risk of developing obesity, hyperlipidemia, hypertension and other physiological alterations characterizing the metabolic syndrome (Desai et al. 2015) . Experimental studies in rodents have further shown that many of these features, including high plasma levels of nonesterified fatty acids, are also present in adult offspring born to protein-restricted dams (Ozanne et al. 1998; Orozco-S olis et al. 2009 ). Since nonesterified fatty acids compete with Trp for the same albumin-binding sites, any increase in the circulating levels of these compounds would result, in theory, in an increased amount of free tryptophan available for transport into the brain. Further studies are nevertheless necessary to confirm this hypothesis.
In conclusion, the results presented here show for the first time that maternal protein restriction induces selective and long-lasting changes in the kynurenine pathway metabolism in the brain of the offspring. Given the key regulatory function of KYN and kynurenine-derived metabolites on neuronal development and brain physiology, these changes might play a role in the cognitive deficits and the enhanced susceptibility to develop psychiatric disorders, such as depression and schizophrenia, exhibited by individuals who were exposed to malnutrition early in life.
